Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Epigallocatechin gallate

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44338   clinical trials with a EudraCT protocol, of which   7368   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    6 result(s) found for: Epigallocatechin gallate. Displaying page 1 of 1.
    EudraCT Number: 2010-023941-31 Sponsor Protocol Number: ETON Start Date*: 2011-05-20
    Sponsor Name:Charité Universitätsmedizin Berlin
    Full Title: Effects of EGCG (Epigallocatechin Gallate) in Chorea Huntington
    Medical condition: Huntington´s Disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-016482-28 Sponsor Protocol Number: SUNIMUD Start Date*: 2010-06-25
    Sponsor Name:Charite Universitätsmedizin Berlin
    Full Title: SUNIMUD - Sunphenon EGCg (Epigallocatechin-Gallate) in Duchenne Muscular Dystrophy
    Medical condition: Duchenne Muscular Dystrophy
    Disease:
    Population Age: Children, Under 18 Gender: Male
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-006323-39 Sponsor Protocol Number: SuniMS-03 Start Date*: 2007-06-19
    Sponsor Name:Charité-Universitätsmedizin Berlin
    Full Title: Sunphenon (Epigallocatechin-Gallate) in relapsing-remitting multiple sclerosis
    Medical condition: relapsing-remitting multiple sclerosis ICD classification: G35.1
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-005943-27 Sponsor Protocol Number: 975 Start Date*: 2007-06-01
    Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
    Full Title: Evaluation of the retinal electrofisiological response in patients with compensated GLAUCOMA POAG in treatment with epigallocatechin-gallate Epinerve .
    Medical condition: glaucoma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10018307 Glaucoma and ocular hypertension HLGT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-005439-26 Sponsor Protocol Number: NL47392.068.13 Start Date*: 2014-04-23
    Sponsor Name:Maastricht University Medical Centre
    Full Title: Topical sinecatechins ointment in treatment of primary superficial Basal Cell Carcinoma: a double blind, randomized, placebo-controlled trial.
    Medical condition: Primary histological proven superficial basal cell carcinoma ≥ 4mm < 20mm outside the H-zone of the face or scalp
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004864 10042503 Superficial basal cell carcinoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-003107-19 Sponsor Protocol Number: 13-0288 Start Date*: 2014-04-28
    Sponsor Name:University of Birmingham [...]
    1. University of Birmingham
    2. Sandwell and West Birmingham Hospitals NHS Trust
    Full Title: Phase II clinical trial investigating the use of epigallocatechin-3-gallate (Veregen) in the treatment of vulval intraepithelial neoplasia
    Medical condition: Vulval intraepithelial neoplasia (VIN)
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004864 10057313 Vulval intraepithelial neoplasia grade III LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 22 21:09:41 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA